- Home
- NBTX vs OXSQ Comparison
NBTX vs OXSQ Comparison
Compare NBTX & OXSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- OXSQ
- Stock Information
- Founded
- NBTX 2003
- OXSQ 2003
- Country
- NBTX France
- OXSQ United States
- Employees
- NBTX N/A
- OXSQ N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- OXSQ Blank Checks
- Sector
- NBTX Health Care
- OXSQ Finance
- Exchange
- NBTX Nasdaq
- OXSQ Nasdaq
- Market Cap
- NBTX 211.9M
- OXSQ 178.7M
- IPO Year
- NBTX 2020
- OXSQ N/A
- Fundamental
- Price
- NBTX $9.70
- OXSQ $2.18
- Analyst Decision
- NBTX Strong Buy
- OXSQ
- Analyst Count
- NBTX 1
- OXSQ 0
- Target Price
- NBTX $8.00
- OXSQ N/A
- AVG Volume (30 Days)
- NBTX 15.1K
- OXSQ 706.2K
- Earning Date
- NBTX 09-18-2025
- OXSQ 11-04-2025
- Dividend Yield
- NBTX N/A
- OXSQ 19.27%
- EPS Growth
- NBTX N/A
- OXSQ N/A
- EPS
- NBTX N/A
- OXSQ N/A
- Revenue
- NBTX N/A
- OXSQ $40,243,556.00
- Revenue This Year
- NBTX N/A
- OXSQ N/A
- Revenue Next Year
- NBTX $74.67
- OXSQ N/A
- P/E Ratio
- NBTX N/A
- OXSQ N/A
- Revenue Growth
- NBTX N/A
- OXSQ N/A
- 52 Week Low
- NBTX $2.76
- OXSQ $2.14
- 52 Week High
- NBTX $10.59
- OXSQ $2.99
- Technical
- Relative Strength Index (RSI)
- NBTX 62.98
- OXSQ 36.86
- Support Level
- NBTX $8.03
- OXSQ $2.18
- Resistance Level
- NBTX $9.14
- OXSQ $2.22
- Average True Range (ATR)
- NBTX 0.56
- OXSQ 0.03
- MACD
- NBTX -0.02
- OXSQ -0.00
- Stochastic Oscillator
- NBTX 68.67
- OXSQ 14.29
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.